Medication info
Astein Tablet 20 mg (Atorvastatin Calcium Hydrate)

Astein Tablet 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201501997 · Approved 2015.04.13 · Insurance code 665001930

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses greater than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • vascular surgeries
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps to reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke and helps to prevent cardiovascular issues such as vascular surgeries and angina. Additionally, it reduces the risk of heart disease in patients with diabetes. It is also used to treat hyperlipidemia by lowering cholesterol and triglycerides while increasing good cholesterol (HDL), thereby improving blood lipid status. It is specifically applicable to pediatric patients with familial hypercholesterolemia to lower their risk of heart disease. Through these effects, it is used to improve cardiovascular health and reduce the risk of heart diseases.

Dosage and Administration

Adult dosage

1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses greater than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication may pose a risk of muscle problems; therefore, if symptoms such as muscle pain or muscle weakness occur, notify your doctor immediately. In particular, if muscle enzyme levels are elevated or myopathy is suspected, the use of this medication should be discontinued. Patients with liver function issues or active liver disease should not take this medication. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this medication. Children under the age of 10 should not take this medication, and adolescents aged 10 and over should take it under a doctor's guidance. Individuals with a history of alcohol abuse or liver disease should use this medication cautiously, and regular liver function tests are required. Elderly individuals have a higher risk of developing myopathy, so muscle condition should be carefully monitored when taking this medication. There are many interactions with other drugs, so caution is needed when taken with certain antibiotics, antifungals, antivirals, antihypertensives, antidiabetics, etc. Particularly, grapefruit juice can increase the blood concentration of this medication, raising the risk of side effects, so excessive intake should be avoided. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur, consult medical personnel immediately, and if necessary, perform blood tests to check muscle enzyme levels. It is important to regularly check liver function and muscle condition while taking this medication. For proper storage, keep it out of reach of children and store it in its original container.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • decreased appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleeds
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensation loss
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • vesicular dermatitis
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • black stools
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • respiratory distress
  • asthma
  • sensory disturbance
  • dizziness
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • increased tension
  • myositis
  • muscle disease
  • arthritis
  • mucous cystitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • increased urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • lethargy
  • vascular neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • color vision deficiency
  • taste loss
  • taste disorder

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.